Prof Mark Dawson
Professor
Centre for Cancer Research
177 Scholarly works
40 Projects
HIGHLIGHTS
2026
Research grants (ARC, NHMRC, MRFF)
Identifying and Targeting Epigenetic Mechanisms of Therapeutic Resistance in Cancer
2022
Journal article
Non-genetic determinants of malignant clonal fitness at single-cell resolution
DOI: 10.1038/s41586-021-04206-72022
Conference Proceedings
SUMOYLATION OF DNMT1 REGULATES RESPONSE TO CATALYTIC INHIBITION OF DNMT1 IN ACUTE MYELOID LEUKAEMIA
DOI: 10.1016/j.exphem.2022.07.1782021
Research grants (ARC, NHMRC, MRFF)
Improving Outcomes for Cancer Patients by Targeting the Epigenome
2020
Journal article
An Erg-driven transcriptional program controls B cell lymphopoiesis.
DOI: 10.1038/s41467-020-16828-y2019
Journal article
Dynamic molecular monitoring reveals that SWI–SNF mutations mediate resistance to ibrutinib plus venetoclax in mantle cell lymphoma
DOI: 10.1038/s41591-018-0243-z2017
Research Grant
Acrf Tumour Heterogeneity Program
RECENT SCHOLARLY WORKS
2026
Journal article
Australia’s erosion of peer review
DOI: 10.1126/science.aei89002026
Journal article
Antigen reactivity defines tissue-resident memory and exhausted T cells in tumors
DOI: 10.1038/s41590-025-02347-92026
Journal article
Gut health is associated with clonal haematopoiesis in older adults with and without HIV: the ARCHIVE longitudinal cohort study
DOI: 10.1136/gutjnl-2025-3376202025
Other
Figure S5 from Inhibition of METTL3 Results in a Cell-Intrinsic Interferon Response That Enhances Antitumor Immunity
DOI: 10.1158/2159-8290.308696182025
Other
Figure S7 from Inhibition of METTL3 Results in a Cell-Intrinsic Interferon Response That Enhances Antitumor Immunity
DOI: 10.1158/2159-8290.308696122025
Other
Table S2 from Inhibition of METTL3 Results in a Cell-Intrinsic Interferon Response That Enhances Antitumor Immunity
DOI: 10.1158/2159-8290.308696062025
Other
Figure S3 from Inhibition of METTL3 Results in a Cell-Intrinsic Interferon Response That Enhances Antitumor Immunity
DOI: 10.1158/2159-8290.308696242025
Other
Table S1 from Inhibition of METTL3 Results in a Cell-Intrinsic Interferon Response That Enhances Antitumor Immunity
DOI: 10.1158/2159-8290.30869609